Integrated Quantitative Investments LLC purchased a new position in shares of Inogen, Inc. (NASDAQ:INGN – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 10,000 shares of the medical technology company’s stock, valued at approximately $92,000.
Several other hedge funds also recently made changes to their positions in the business. AlphaQuest LLC acquired a new position in Inogen during the fourth quarter worth $43,000. Meeder Asset Management Inc. bought a new stake in Inogen during the 4th quarter worth about $56,000. Quarry LP acquired a new position in shares of Inogen during the 3rd quarter worth about $59,000. Ieq Capital LLC bought a new position in shares of Inogen in the 4th quarter valued at about $94,000. Finally, Intech Investment Management LLC acquired a new stake in shares of Inogen in the fourth quarter valued at about $94,000. 89.94% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms have issued reports on INGN. StockNews.com lowered shares of Inogen from a “buy” rating to a “hold” rating in a research report on Wednesday, February 26th. Needham & Company LLC reiterated a “hold” rating on shares of Inogen in a research note on Wednesday, February 26th.
Inogen Trading Down 0.1 %
INGN opened at $7.04 on Friday. The stock’s fifty day simple moving average is $9.01 and its 200 day simple moving average is $9.39. Inogen, Inc. has a 1-year low of $6.14 and a 1-year high of $13.33. The stock has a market cap of $189.28 million, a PE ratio of -3.13 and a beta of 1.16.
Inogen Company Profile
Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Read More
- Five stocks we like better than Inogen
- When to Sell a Stock for Profit or Loss
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- 5 Top Rated Dividend Stocks to Consider
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Want to see what other hedge funds are holding INGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inogen, Inc. (NASDAQ:INGN – Free Report).
Receive News & Ratings for Inogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inogen and related companies with MarketBeat.com's FREE daily email newsletter.
